Cite

HARVARD Citation

    Bost, V. et al. (2015). Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen‐HCl–UVA (Intercept™) over a 5‐year period of extensive delivery. Vox sanguinis. 109 (4), pp. 414-416. [Online]. 
  
Back to record